Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus
- PMID: 7865979
- DOI: 10.1007/BF00180544
Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus
Abstract
Nephrogenic diabetes insipidus (NDI) is a serious side effect of various drugs. Elevated renal prostaglandin E2 levels have been found in patients with lithium-induced NDI and have been implicated in the pathogenesis. We report the case of a patient who developed NDI following treatment with amphotericin B. Prostaglandin levels were elevated. Indomethacin had an antidiuretic effect and normalized prostaglandin levels.